nytimes.com / .nytimes-com-health / Page 3

Traditional gene editing rewrites DNA. But a new approach, called epigenome editing, aims to treat the molecular scars we collect throughout our lives.

Patients sued by Senator Roger Marshall of Kansas were routinely charged 18 percent interest, The Times found. Some had bank accounts garnished.

Artificial intelligence was used to help develop a drug candidate, rentosertib, for a rare lung condition. Its maker says the drug also seems to reduce the biological hallmarks of age.

Continuing care retirement communities are widening their scope to help retirees age in place, with measured supports and a way to cap the soaring costs of aging.

The affected frozen fruit products, which were distributed to 19 states and to retailers like Walmart and Publix, were recalled starting in July.

As Dr. Anthony Fauci has faced public scrutiny from congressional Republicans, the D.O.J. has pursued a quieter and more expansive effort against a wider circle of researchers.

Doctors were hopeful the drug, which was being tested in a large clinical trial by Novartis, was going to be a powerful new tool to fight heart disease.

In a legal deposition, the doctor, Theresa Long, compared immunizing service members against Covid to Nazi doctors experimenting on concentration camp prisoners.

Under a new partnership, the Defense Department would play a larger role in biodefense and pandemic preparedness. Democrats warned it could allow a Pentagon cash grab.

Harness that back-to-school energy to set some new goals.